| abstract |
compound, prodrug ester, pharmaceutical composition, and use of a compound provided are compounds having an inhibitory effect on the sgl t sodium-dependent glucose transporter. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, to treat diseases and conditions that are affected by sglt inhibition. |